Validation of an Ovarian Adnexal Mass Assessment Score Test System in Women With an Ovarian Mass

Cleo Diagnostics Ltd0 个研究点目标入组 500 人开始时间: 2024年7月19日最近更新: 2024年7月29日

适应症

试验速览

暂无简介。

•1. Female patients => 18 years of age at the time of consent
•2. Can provide written informed consent
•3. Have an ovarian cyst or adnexal mass (simple, complex, or solid ovarian/pelvic mass) identified through imaging examination (transvaginal ultrasound - TVU) that requires surgery, but have not yet undergone surgery

•1.Pregnant currently / within the last 3 months
•2.Current or previous ovarian cancer
•3.Prior bilateral oophorectomy or otherwise in surgical menopause
•4.Diagnosed with any gynecological malignancy within last 2 years
•5.Diagnosed with melanoma within last 2 years
•6.Current or prior (previous 12 months) treatment with chemotherapy, radiotherapy or immunotherapy
•7.Immune-compromised – defined as those whose weakened immune system may render them more susceptible to infection, illness, or complications. These may include patients with immune-suppressive conditions (e.g. HIV/AIDS), patients undergoing immuno-, chemo- or radio-therapy (within the last 12 months) for any reason, receiving immune suppressive therapies (e.g. transplant recipients, individuals with known autoimmune disease), or with a primary immunodeficiency disorder (e.g. Lupus).

发起方